- Lupin initiates recall of tablet Mibelas 24 Fe from US market
According to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'clas...
24 Aug, 2017, 02.32 PM IST
Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
21 Jan, 2016, 12.29 PM IST
Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
06 Jan, 2016, 06.51 PM IST
Lupin gets USFDA nod for generic oral contraceptive tabletsLupin today said it has received US health regulator's final approval to market Blisovi oral contraceptive tablets in different strengths i...
24 Nov, 2015, 08.35 PM IST
Glenmark gets USFDA final nod for contraceptive tabletsThe approval marks the company's 12th oral contraceptive and 2nd extended-cycle oral contraceptive authorised for distribution by the USFDA.
15 Jun, 2015, 03.25 PM IST
Lupin gains on FDA approval for oral contraceptiveShares of Lupin gained momentum in weak market after it received US FDA approval for oral contraceptive tablets.
30 Sep, 2013, 10.19 AM IST
Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
26 Apr, 2013, 04.10 PM IST
Oral Contraceptives Booster to Lupin's US businessAs per the IMS data, the total sales for branded and generic sales for the product stood at $ 361 million for the year ended December 2012.
17 Apr, 2013, 06.35 PM IST
Lupin gets USFDA approval for oral contraceptive tabletsLupin today said it has received US health regulator's approval to market Drospirenone and Ethinyl Estradiol Tablets, an oral contraceptive...
19 Dec, 2012, 05.37 PM IST
- Lupin gets USFDA nod to market generic contraceptive tablets
Drug firm Lupin today said it has received final approval from the US health regulator to market its generic Levonorgestrel and Ethinyl Est...
25 Oct, 2012, 05.15 PM IST
- Lupin gets USFDA approval for oral contraceptive tablets Kurvelo
Drug firm Lupin today said its subsidiary has received American health regulator's approval to market its generic oral contraceptive tablet...
18 Oct, 2012, 06.12 PM IST
- Glenmark recalls select lot of oral contraceptive in US
Glenmark Pharmaceuticals today said it has issued a voluntary nationwide recall in the US for seven lots of its oral contraceptive Norgesti...
25 Feb, 2012, 02.52 PM IST
- Glenmark Pharmaceuticals gets USFDA approval for oral contraceptives
Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for its generic two oral contraceptives tab...
20 Jan, 2012, 01.41 PM IST
- Lupin eyes $150 mn from oral contraceptives in US by FY14
Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
27 Nov, 2011, 01.42 PM IST
- Lupin gets USFDA nod for generic oral contraceptive tablets
Lupin has received approval from USFDA to sell 'LoSeasonique' tablets, an oral contraceptive drug, in the American mkt.
28 Oct, 2011, 05.20 PM IST
- Lupin gains on USFDA nod; Goldman recommends 'Buy'
Shares of drugmaker Lupin rose nearly 2 percent after it received the US regulatory approval on Tuesday to launch oral contraceptive
21 Sep, 2011, 11.50 AM IST
- Lupin gets FDA approval for oral contraceptive
LPI has been granted final approval by the US FDA for its ANDA to market a generic version of Watson's NOR-QD® tablets.
20 Sep, 2011, 04.31 PM IST